PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-35.35%
Both companies show declining cash positions (-35.35% vs RVPH's -36.42%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-35.35%
Similar yoy growth to RVPH's -36.42%. Walter Schloss would note comparable liquidity expansions. Examine capital usage strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
45.32%
Other current assets growth < half of RVPH's -59.41%. David Dodd sees a leaner approach to short-term items.
-30.67%
0.75-0.9x RVPH's -39.97%. Bill Ackman would ask if competitor is building short-term resources more aggressively.
-13.90%
Both RVPH and the company show zero PP&E (Net) Growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.03%
Less than half of RVPH's 0.46%. David Dodd sees fewer expansions in non-core assets. Possibly a simpler focus.
-10.42%
Below half of RVPH's 0.46%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-28.48%
Below half of RVPH's 0.31%. Michael Burry sees a potential red flag for stagnation or capital shortage.
-10.38%
Higher Accounts Payable Growth compared to RVPH's zero value, indicating worse performance.
1404.09%
Higher Short-Term Debt Growth compared to RVPH's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
10.38%
Higher Deferred Revenue (Current) Growth compared to RVPH's zero value, indicating better performance.
No Data
No Data available this quarter, please select a different quarter.
-3.56%
Less than half of RVPH's 195.06%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-18.88%
Higher Total Non-Current Liabilities Growth compared to RVPH's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-5.58%
Less than half of RVPH's 2.94%. David Dodd sees far fewer liability expansions relative to competitor.
No Data
No Data available this quarter, please select a different quarter.
-2.25%
Below half RVPH's 11.53%. Michael Burry suspects major net losses or high dividends vs. competitor.
-5.49%
Higher AOCI Growth compared to RVPH's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-43.19%
Below half RVPH's 0.00%. Michael Burry sees potential underperformance in building shareholder capital.
-28.48%
Below half RVPH's 0.91%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
14.13%
Higher Total Debt Growth compared to RVPH's zero value, indicating worse performance.
40.09%
1.1-1.25x RVPH's 36.42%. Bill Ackman questions if net debt is increasing faster than competitor.